Funds holding iShares Biotechnology ETF
ISIN US4642875565 · United States · LEI 549300S7IVD88MPK0066
- Fund holders
- 7
- Of which ETFs
- 2 5 other funds
- Value held
- 13.1M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Allspring Small Company Value Portfolio ALLSPRING MASTER TRUST | 33,987 | 5.7M $ | 0.88 % | as of Apr 30, 2026 ↗ |
| Leuthold Core ETF Managed Portfolio Series | 12,088 | 2M $ | 3.00 % | as of Mar 31, 2026 ↗ |
| VictoryShares WestEnd Global Equity ETF Victory Portfolios II | 9,087 | 1.5M $ | 3.28 % | as of Mar 31, 2026 ↗ |
| WesMark Tactical Opportunity Fund WesMark Funds | 8,647 | 1.5M $ | 2.91 % | as of Mar 31, 2026 ↗ |
| Buffalo Blue Chip Growth Fund Buffalo Funds | 6,125 | 1M $ | 0.65 % | as of Mar 31, 2026 ↗ |
| Wellington Shields All-Cap Fund CAPITAL MANAGEMENT INVESTMENT TRUST | 4,000 | 701.5K $ | 1.01 % | as of Feb 28, 2026 ↗ |
| SGI Small Cap Core Fund RBB Fund, Inc. | 3,471 | 608.7K $ | 0.50 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures how much this security weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| VictoryShares WestEnd Global Equity ETF Victory Portfolios II | 3.28 % | as of Mar 31, 2026 ↗ |
| Leuthold Core ETF Managed Portfolio Series | 3.00 % | as of Mar 31, 2026 ↗ |
| WesMark Tactical Opportunity Fund WesMark Funds | 2.91 % | as of Mar 31, 2026 ↗ |
| Wellington Shields All-Cap Fund CAPITAL MANAGEMENT INVESTMENT TRUST | 1.01 % | as of Feb 28, 2026 ↗ |
| Allspring Small Company Value Portfolio ALLSPRING MASTER TRUST | 0.88 % | as of Apr 30, 2026 ↗ |
| Buffalo Blue Chip Growth Fund Buffalo Funds | 0.65 % | as of Mar 31, 2026 ↗ |
| SGI Small Cap Core Fund RBB Fund, Inc. | 0.50 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 7 | -4 | 77,405 | -76.9 % |
| 2026Q1 | 11 | +1 | 335,600 | -32.6 % |
| 2025Q4 | 10 | +7 | 498,174 | +3,035.7 % |
| 2025Q3 | 3 | 0 | 15,887 | -3.7 % |
| 2025Q2 | 3 | -10 | 16,497 | -98.1 % |
| 2025Q1 | 13 | 0 | 865,232 | +4.3 % |
| 2024Q4 | 13 | +6 | 829,323 | +28.6 % |
| 2024Q3 | 7 | +3 | 645,057 | +10.9 % |
| 2024Q2 | 4 | -2 | 581,470 | -8.7 % |
| 2024Q1 | 6 | +4 | 637,120 | +1,740.9 % |
| 2023Q4 | 2 | 34,610 |
Institutional managers
912 managers declare this security to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | 7,259,501 | 1.2B $ | as of Mar 31, 2026 |
| CITIGROUP INC | 5,122,689 | 865M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 2,773,467 | 468.3M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 2,460,954 | 398.3M $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 2,429,567 | 410.2M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,275,806 | 215.4M $ | as of Mar 31, 2026 |
| ENVESTNET ASSET MANAGEMENT INC | 1,226,668 | 207.1M $ | as of Mar 31, 2026 |
| RAYMOND JAMES FINANCIAL INC | 1,029,709 | 173.9M $ | as of Mar 31, 2026 |
| COMMERCE BANK | 881,632 | 148.9M $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 854,345 | 144.3M $ | as of Mar 31, 2026 |
| UBS Group AG | 814,290 | 137.5M $ | as of Mar 31, 2026 |
| Thrivent Financial for Lutherans | 772,812 | 130.5K $ | as of Mar 31, 2026 |
| ROYAL BANK OF CANADA | 737,128 | 124.5M $ | as of Mar 31, 2026 |
| LPL Financial LLC | 724,989 | 122.4M $ | as of Mar 31, 2026 |
| TRUIST FINANCIAL CORP | 666,343 | 112.5M $ | as of Mar 31, 2026 |
| Janney Montgomery Scott LLC | 652,818 | 110.2K $ | as of Mar 31, 2026 |
| WestEnd Advisors, LLC | 648,103 | 109.4M $ | as of Mar 31, 2026 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 596,000 | 100.6M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 557,807 | 94.2M $ | as of Mar 31, 2026 |
| BARCLAYS PLC | 450,734 | 76.1M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 389,056 | 65.7M $ | as of Mar 31, 2026 |
| PNC FINANCIAL SERVICES GROUP, INC. | 318,588 | 53.8M $ | as of Mar 31, 2026 |
| Jefferies Financial Group Inc. | 302,307 | 51M $ | as of Mar 31, 2026 |
| VICTORY CAPITAL MANAGEMENT INC | 226,236 | 38.2M $ | as of Mar 31, 2026 |
| STIFEL FINANCIAL CORP | 157,318 | 26.6M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding iShares Biotechnology ETF". https://titelia.com/en/stocks/ishares-biotechnology-etf-US4642875565